The high cost of insulin has prompted some Americans toration the lifesaving drug.
Eli Lilly is one of just three major insulin producers, along with Novo Nordisk and Sanofi.
Together, the three companies are estimated tocontrol over 90% of the global insulin market.
The American Diabetes Associationpraised Eli Lilly’s moveand encouraged other insulin makers to do the same.
Last month President Joe Bidencalled on Congressto cap the price of insulin for all people with diabetes.
